Ethical challenges for pediatric liver organoid transplantation
- 15 July 2020
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (552)
- https://doi.org/10.1126/scitranslmed.aau8471
Abstract
Liver organoid transplantation may be a less invasive alternative to liver transplant, but is it ethically acceptable to include children with liver disease in a first-in-human clinical trial of this new intervention?Funding Information
- ZonMw The Netherlands Organisation for Health Research and Development Health Institute (40007039713537)
- ZonMw The Netherlands Organisation for Health Research and Development Health Institute (731010020)
- Metakids Funding (2017-072)
- Leading Ladies Fund from the Wilhelmina Children’s Hospital
This publication has 7 references indexed in Scilit:
- Long-Term Survival of Transplanted Autologous Canine Liver Organoids in a COMMD1-Deficient Dog Model of Metabolic Liver DiseaseCells, 2020
- Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D OrganoidsCell, 2018
- Is Participation in Cancer Phase I Trials Really Therapeutic?Journal of Clinical Oncology, 2017
- Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human LiverCell, 2014
- Organogenesis in a dish: Modeling development and disease using organoid technologiesScience, 2014
- Present status and perspectives of cell-based therapies for liver diseasesJournal of Hepatology, 2006
- What Makes Clinical Research Ethical?JAMA, 2000